Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 9:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ibogaine by David Dardashti Celebrates 22 Years of Innovating Suboxone, Methadone, and Kratom Addiction Treatment
- Eureka Ergonomic Announces the Mathias Collection, Highlighting a Refined Design Language for Modern Executive Spaces
- LiveOne (NASDAQ:LVO) Acquires 1.47M PodcastOne (NASDAQ:PODC) Common Shares Since March 31, 2026 at $2.81/Share Average; Increases PODC Ownership to 20.8M Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
